Patients’ access to biologics in rheumatoid arthritis: a comparison between Portugal and other European countries

Variations in RA PAB were found across selected countries with Portugal showing the lowest proportion. GDP per capita, biologics distribution channel and consumption of MTX appear to be the best explanatory factors for these fluctuations in European countries. </AbstractSection> Copyright Springer-Verlag 2013

MoreLess

Year of publication:	2013
Authors:	Laires, P. ; Exposto, F. ; Mesquita, R. ; Martins, A. ; Cunha-Miranda, L. ; Fonseca, J.
Published in:	The European Journal of Health Economics. - Springer. - Vol. 14.2013, 6, p. 875-885
Publisher:	Springer
Subject:	Rheumatoid arthritis \| Treatment access \| Biologics \| Portugal

More details

Extent:	text/html
Type of publication:	Article
Source:	RePEc - Research Papers in Economics

Persistent link: https://www.econbiz.de/10010993995